opioid addiction

Trump administration will let nearly all doctors prescribe addiction medicine buprenorphine
Trump administration will let nearly all doctors prescribe addiction medicine buprenorphine
Stat
opioid use disorder
opioid addiction
opioids
Donald Trump
buprenorphine
physicians
Flag link:
Addiction firm Orexo licenses app for alcohol use disorder
Addiction firm Orexo licenses app for alcohol use disorder
Pharmaforum
Orexo
opioid addiction
digital therapy
Vorvida
Flag link:
Orexo partners with Gaia on digital opioid abuse therapeutic
Orexo partners with Gaia on digital opioid abuse therapeutic
Pharmaforum
Orexo
Gaia Healthcare
digital therapeutics
opioid use disorder
opioid addiction
Flag link:
FDA to reconsider Braeburn’s opioid addiction drug after court ruling
FDA to reconsider Braeburn’s opioid addiction drug after court ruling
Pharmaforum
FDA
opioids
opioid addiction
Braeburn Pharmaceuticals
Indivior
Brixadi
Flag link:
Reckitt Benckiser Group PLC agrees to pay $1.4 billion to settle whistleblower cases
Reckitt Benckiser Group PLC agrees to pay $1.4 billion to settle whistleblower cases
CP Wire
whistleblower lawsuits
Reckitt Benckiser
FTC
opioids
opioid addiction
Suboxone
Flag link:
Reckitt Benckiser Group PLC agrees to pay $1.4 billion to settle whistleblower cases
whistleblower lawsuits
Reckitt Benckiser
FTC
opioids
opioid addiction
Suboxone
Flag link:
Billion-dollar settlment gets Reckitt out of federal opioid probes
Billion-dollar settlment gets Reckitt out of federal opioid probes
Biopharma Dive
Reckitt Benckiser
opioids
opioid crisis
opioid addiction
Indivior
Suboxone
Flag link:
While addiction crisis raged, many surgeons overprescribed opioids, analysis shows
While addiction crisis raged, many surgeons overprescribed opioids, analysis shows
Stat
opioids
opioid crisis
opioid addiction
Flag link:
Teva settles Oklahoma opioid lawsuit ahead of trial
Teva settles Oklahoma opioid lawsuit ahead of trial
Pharmaforum
Teva Pharmaceutical
opioids
opioid addiction
Oklahoma
Flag link:
Addiction Medicine Mostly Prescribed To Whites, Even As Opioid Deaths Rose In Blacks
Addiction Medicine Mostly Prescribed To Whites, Even As Opioid Deaths Rose In Blacks
NPR
racial discrimination
opioid addiction
Flag link:
Nearly all doctors can freely prescribe opioids. Now a new movement aims to vastly deregulate an addiction treatment
Nearly all doctors can freely prescribe opioids. Now a new movement aims to vastly deregulate an addiction treatment
Stat
opioids
opioid crisis
opioid addiction
physicians
Flag link:
White House Continues to Tackle Opioid Abuse With $350 Million R&D Initiative
White House Continues to Tackle Opioid Abuse With $350 Million R&D Initiative
BioSpace
opioid addiction
R&D
Flag link:
US court rejects Indivior’s appeal on Suboxone generic version
US court rejects Indivior’s appeal on Suboxone generic version
Pharmaceutical Business Review
Indivior
generics
Suboxone Film
Dr Reddy's
opioid addiction
Flag link:
Document: Facing blame for seeding the opioid crisis, Purdue explored its next profit opportunity — treating addiction
Document: Facing blame for seeding the opioid crisis, Purdue explored its next profit opportunity — treating addiction
Stat
Purdue Pharma
opioids
oxycontin
opioid crisis
opioid addiction
Flag link:
BioCorRx wins $5.6m grant for sustained release naltrexone implant
BioCorRx wins $5.6m grant for sustained release naltrexone implant
Drug Delivery Business News
devices
BioCorRx
NIH
naltrexone implant
opioid use disorder
opioid addiction
Flag link:
Indivior temporarily stops rival Alvogen's generic launch
Indivior temporarily stops rival Alvogen's generic launch
Reuters
Indivior
Alvogen
generics
opioid addiction
Suboxone
Flag link:
BioCentury - ‘Tentative’ FDA approval for Braeburn's opioid addiction product
BioCentury - ‘Tentative’ FDA approval for Braeburn's opioid addiction product
BioCentury
Braeburn Pharmaceuticals
FDA
Brixadi buprenorphine
opioid addiction
Flag link:
Purdue’s secret OxyContin papers should be released, appeals court rules
Purdue’s secret OxyContin papers should be released, appeals court rules
Stat
Purdue Pharma
oxycontin
opioid addiction
opioids
Flag link:
Kaleo, maker of $4,100 overdose antidote, authorizes a generic version for just $178
Kaleo, maker of $4,100 overdose antidote, authorizes a generic version for just $178
Stat
Kaleo
opioids
opioid addiction
generics
Naloxone
Evzio
opioid overdose
Flag link:
A drug maker boosted the price of its opioid-overdose antidote by 600 percent, and taxpayers suffered
A drug maker boosted the price of its opioid-overdose antidote by 600 percent, and taxpayers suffered
Stat
Naloxone
Kaleo
drug pricing
opioids
opioid addiction
Evzio
Flag link:

Pages